Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes.
Kroon, Frank P.; van Dissel, Jaap T.; de Jong, Jan C. *; van Furth, Ralph
8(4):469-476, April 1994.
(Format: HTML, PDF)
Objective: To establish when the formation of antibodies against T-lymphocyte-dependent and -independent antigens is impaired during HIV infection.
Design: Prospective study on antibody formation before and 30 days and 60 days after vaccination with tetravalent influenza vaccine, tetanus toxoid and pneumococcal vaccine; booster with influenza vaccine was administered 30 days after initial vaccination.
Setting: Outpatient clinic of University Hospital Leiden.
Participants: Fifty-one HIV-infected individuals and 10 healthy controls.
Results: In HIV-infected individuals with <100x106/l CD4 lymphocytes almost no influenza antibodies were formed; CD4 counts between 100 and 300 x 106/l correlated with suboptimal antibody formation; CD4 counts <=300x106/l yielded more individuals with protective antibody titres. Thirty days after vaccination, protective antibody titres against the four influenza strains had been achieved in 24% of all HIV-infected individuals for A/Beijing (H3N2) (controls, 90%), 59% for A/Taiwan (H1N1) (controls, 80%), 18% for B/Beijing (controls, 30%) and 37% for B/Panama (controls 90%). Booster vaccination after 1 month did not increase antibody levels. Anti-tetanus toxin antibody formation, which is also T-lymphocyte-dependent, was correlated with the number of CD4 lymphocytes. After pneumococcal vaccination (T-lymphocyte-independent), normal antibody formation was observed in HIV-infected individuals, including those with low CD4 counts.
Conclusions: Influenza vaccination should not be administered to HIV-infected individuals with CD4 counts <100x106/l; pneumococcal vaccination can be offered to all HIV-infected individuals and a tetanus toxoid booster should be administered when indicated.
(C) Lippincott-Raven Publishers.